DUBLIN - Investment firm Trium Capital LLP has disclosed a 1.16% stake in Avadel Pharmaceuticals PLC, according to a regulatory filing published Friday. The disclosure, made under Irish Takeover Panel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback